atorvastatin has been researched along with Arterial Occlusive Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cameron, SJ; Doyle, A; Mix, D; Parsons, MR; Stoner, MC | 1 |
| Bregar, U; Jug, B; Poredos, P; Sabovic, M; Sebestjen, M | 1 |
| Kröger, K; Wittlinger, T | 1 |
| Bucek, RA; Minar, E; Pourazim, A; Reiter, M; Wirth, S | 1 |
| El Menjawi, I; Fladerer, P; Krause, R; Pohanka, E; Wenisch, C | 1 |
| Criqui, MH | 1 |
2 review(s) available for atorvastatin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Role of lipid lowering therapy in patients with peripheral arterial occlusive disease].
Topics: Anticholesteremic Agents; Arterial Occlusive Diseases; Atorvastatin; Disease Progression; Exercise Test; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Jejunoileal Bypass; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Simvastatin; Treatment Outcome | 2004 |
Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Arterial Occlusive Diseases; Arteriosclerosis; Atorvastatin; Cholesterol; Clinical Trials as Topic; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Pyrroles; Risk Factors; Survival Rate | 2001 |
1 trial(s) available for atorvastatin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
The influence of atorvastatin on walking performance in peripheral arterial disease.
Topics: Aged; Anticholesteremic Agents; Arterial Occlusive Diseases; Atorvastatin; Cholesterol, LDL; Combined Modality Therapy; Diet, Fat-Restricted; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Intermittent Claudication; Male; Middle Aged; Pyrroles; Statistics, Nonparametric; Walking | 2009 |
3 other study(ies) available for atorvastatin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Lights Out: An Unusual Case of Amaurosis Fugax.
Topics: Amaurosis Fugax; Angiography, Digital Subtraction; Anticholesteremic Agents; Arterial Occlusive Diseases; Aspirin; Atorvastatin; Brachiocephalic Trunk; Clopidogrel; Computed Tomography Angiography; Drug Therapy, Combination; Female; Humans; Middle Aged; Platelet Aggregation Inhibitors; Stents; Stroke; Vertigo | 2018 |
Influence of HMG-CoA-reductase inhibitors on the body fat status.
Topics: Adipose Tissue; Aged; Arterial Occlusive Diseases; Atorvastatin; Body Composition; Body Mass Index; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Retrospective Studies; Simvastatin | 2006 |
Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
Topics: Acute Disease; Aged; Angioplasty, Balloon; Anti-Bacterial Agents; Arterial Occlusive Diseases; Atorvastatin; Drug Therapy, Combination; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Pyrroles; Rhabdomyolysis; Risk Factors; Surgical Wound Infection; Tibial Arteries | 2000 |